Bernard Coulie - President and CEO, Director at Pliant Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
PLRX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Bernard Coulie - trading volume in the past year for Pliant Therapeutics, Inc.

Holdings reported by Bernard Coulie for Pliant Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 483K $5.58M $11.56 Jul 10, 2024 Direct
Common Stock 409K $4.73M $11.56 Jul 10, 2024 Indirect
Stock Option (Right to Buy) 256K Jan 23, 2024 Direct Common Stock

Transactions reported by Bernard Coulie for Pliant Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.